Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03635983
Recruitment Status : Active, not recruiting
First Posted : August 17, 2018
Last Update Posted : August 3, 2022
Nektar Therapeutics
Information provided by (Responsible Party):
Bristol-Myers Squibb

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : November 19, 2021
Estimated Study Completion Date : February 28, 2024